Xiangyu Medical Co

Xiangyu Medical Co OCF Margin

The Operating Cash Flow Margin of Xiangyu Medical Co (688626.SS) as of Nov 3, 2026 is 24.72 %. In the previous year, Operating Cash Flow Margin was 24.02 % — a change of 2.93% (higher).

OCF Margin

24.72 %

YoY

2.93%

Last updated:

Operating Cash Flow Margin of Xiangyu Medical Co is 2025 24.72 % . Operating Cash Flow Margin of Xiangyu Medical Co was 2024 24.02 % . It decreases by 2.93% higher compared to the previous year.

The Xiangyu Medical Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
20.68 CNY
Jan 1, 2019
36.49 CNY
Jan 1, 2020
43.67 CNY
Jan 1, 2021
31.69 CNY
Jan 1, 2022
38.22 CNY
Jan 1, 2023
30.60 CNY
Jan 1, 2024
24.02 CNY
Jan 1, 2025
24.72 CNY
The Xiangyu Medical Co OCF Margin history
YEAROCF MarginYoY
24.72 %+2.93%
24.02 %-21.50%
30.60 %-19.93%
38.22 %+20.61%
31.69 %-27.44%
43.67 %+19.70%
36.49 %+76.46%
20.68 %+0.79%
20.51 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Xiangyu Medical Co Stock analysis

What does Xiangyu Medical Co do? Xiangyu Medical Co., Ltd. develops, produces, and sells rehabilitation medical equipment, focusing on intelligent rehabilitation solutions for pain, neurology, orthopedics, traditional Chinese medicine, postpartum, postoperative, and cardiopulmonary fields. The company offers three main product categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy. It primarily serves the domestic market within China, leveraging its independent research and development capabilities to address diverse rehabilitation needs across multiple medical specialties. The firm's revenue is generated through the sale of its intelligent rehabilitation equipment, with products targeting healthcare facilities, hospitals, and rehabilitation centers. These institutions purchase the equipment to support patient recovery in specialized areas such as neurology, orthopedics, and postpartum care. Xiangyu Medical's domestic market focus ensures consistent demand for its tailored rehabilitation solutions. Xiangyu Medical's business model centers on in-house research and development, enabling the creation of specialized equipment that meets the specific requirements of rehabilitation fields. By concentrating on domestic sales, the company avoids complex international distribution challenges while maintaining a strong presence in China's growing healthcare sector. The company's product portfolio aligns with the expanding demand for integrated medical care solutions within China's healthcare system. Xiangyu Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xiangyu Medical Co stock

Operating Cash Flow Margin of Xiangyu Medical Co is 24.72 % in 2025.

Operating Cash Flow Margin of Xiangyu Medical Co changed from 24.02 % to 24.72 %, representing a 2.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Xiangyu Medical Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Xiangyu Medical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Xiangyu Medical Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Xiangyu Medical Co